Connection
Anne Fuhlbrigge to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications Anne Fuhlbrigge has written about Clinical Trials, Phase II as Topic.
|
|
Connection Strength |
|
|
|
|
|
0.046 |
|
|
|
-
Vogelmeier CF, Fuhlbrigge A, Jauhiainen A, Scheepers LEJM, Bengtsson T, Peterson S, Karlsson N, Sethi T, Locantore N, Tal-Singer R, Rennard S, Fager?s M, Da Silva CA. COPDCompEx: A novel composite endpoint for COPD exacerbations to enable faster clinical development. Respir Med. 2020 11; 173:106175.
Score: 0.046